S5
S5YA.F Sigma Healthcare Limited
- Market cap
- EUR 20.0B
- P/E
- 43.3x
- P/B
- 6.54x
- ROE
- 14.2%
- Dividend yield
- 1.43%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jan 2026.
Is S5YA.F undervalued?
Graham numberThe Graham number of Sigma Healthcare Limited cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Sigma Healthcare Limited fundamental analysis
No fundamental analysis for Sigma Healthcare Limited yet.
Sigma Healthcare Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Sigma Healthcare Limited
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally. It is involved in the wholesale distribution of pharmaceutical, medical, healthcare and beauty products to a network of franchised retail pharmacies, and other third parties; advertising and marketing services; and provision of support services to a network of retail pharmacies. The company also provides MPS…
Full company profileSigma Healthcare Limited financial statements
Sigma Healthcare Limited annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 4.42B | 4.13B | 4.02B | 3.24B | 3.40B | 3.45B | 3.73B | 3.38B | 6.00B | 10.8B |
| Gross Profit | 344M | 284M | 313M | 215M | 239M | 227M | 321M | 272M | 1.44B | 1.96B |
| Operating Income | 69.8M | 269K | 3.07M | -101M | -75.2M | -110M | -9.18M | -18.2M | 667M | 907M |
| EBITDA | - | 94.3M | 77.3M | 24.9M | 94.6M | 30.2M | 50.2M | 53.3M | 833M | 1.14B |
| Net Income | 53.2M | 55.1M | 36.5M | -12.3M | 59.8M | -7.24M | 1.81M | 4.51M | 530M | 709M |
| EPS | - | 0.05 | 0.03 | -0.01 | 0.06 | -0.01 | 0.00 | 0.00 | 0.32 | 0.06 |
| Balance Sheet | ||||||||||
| Total Assets | 1.12B | 1.31B | 1.38B | 1.21B | 1.21B | 1.25B | 1.17B | 1.38B | 1.83B | 8.91B |
| Total Liabilities | 580M | 793M | 870M | 735M | 671M | 760M | 696M | 505M | 991M | 3.92B |
| Shareholders' Equity | 537M | 513M | 513M | 476M | 534M | 487M | 476M | 871M | -1.42M | 5.00B |
| Cash & Short-term Investments | 24.4M | 82.2M | 72.6M | 104M | 16.1M | 31.1M | 16.7M | 356M | 14.6M | 131M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 146M | 71.2M | 8.47M | 203M | -13.1M | -46.3M | 143M | - | - | - |
| Capital Expenditure | 27.3M | 62.3M | 108M | 57.1M | 51.4M | 14.2M | 29.4M | 4.72M | 57.6M | 56.7M |
| Free Cash Flow | - | 3.16M | -99.7M | 143M | -64.6M | -60.5M | 113M | 37.2M | 541M | 518M |
| Ratios | ||||||||||
| ROE | 9.9% | 10.7% | 7.1% | -2.6% | 11.2% | -1.5% | 0.4% | 0.5% | - | 14.2% |
| ROA | 4.8% | 4.2% | 2.6% | -1.0% | 5.0% | -0.6% | 0.2% | 0.3% | 28.9% | 8.0% |
| Net Profit Margin | 1.2% | 1.3% | 0.9% | -0.4% | 1.8% | -0.2% | 0.0% | 0.1% | 8.8% | 6.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Sigma Healthcare Limited dividends
- Dividend yield
- 1.43%
- Forward dividend
- 0.02 EUR
- Payout ratio
- 53.4%
- Ex-dividend date
- Sep 3, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | AUD 379M | 0.03 | 53.4% |
| 2025 | AUD 1.19B | 0.73 | 223.8% |
| 2024 | AUD 10.8M | 0.01 | 239.3% |
| 2023 | AUD 15.0M | 0.01 | 826.1% |
| 2022 | AUD 19.9M | 0.02 | - |
| 2021 | AUD 19.9M | 0.02 | 33.3% |
| 2020 | EUR 29.6M | 0.03 | - |
| 2019 | EUR 39.3M | 0.04 | 107.7% |
| 2018 | EUR 55.2M | 0.05 | 100.3% |
| 2017 | EUR 55.7M | - | 104.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Sigma Healthcare Limited
- Insiders 53.68%
- Institutions 11.78%
- Public & others 34.54%
- Shares outstanding 11.5B
- Free float 5.10B
Sigma Healthcare Limited company profile
- Company name
- Sigma Healthcare Limited
- Ticker
- S5YA.F
- ISIN
- AU000000SIG5
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Fiscal year end
- January
- Address
- 6 Albert Street, Preston, VIC, Australia, 3072
- Phone
- 61 3 9215 9215
- Website
- sigmahealthcare.com.au
About Sigma Healthcare Limited
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally. It is involved in the wholesale distribution of pharmaceutical, medical, healthcare and beauty products to a network of franchised retail pharmacies, and other third parties; advertising and marketing services; and provision of support services to a network of retail pharmacies. The company also provides MPS Connect, a end-to-end medication management solution. The company operates stores under the Chemist Warehouse, Amcal, and Discount Drug stores, and PriceSave brand names. It also offers products online. The company was founded in 1912 and is headquartered in Preston, Australia.
Sigma Healthcare Limited management
8- Mr. Vikesh Ramsunder B.Com.CEO, MD & Executive Director · born 1971
- Mr. Richard Murray ASIA, B.Com., B.Comm, C.A., F.C.A., Grad.Dip.Chief Financial Officer
- Ms. Danielle Di Pilla B.Sc.Chief People Officer & Executive Director
- Mr. Mario VerrocchiCEO of Retail & Executive Director
- Mr. Gary WoodfordHead of Corporate Affairs and Investor Relations
- Ms. Kara McGowan A.C.I.S., B.Com., L.L.B.General Counsel & Chief Legal Officer and Company Secretary
- Mr. Mark Brendan Conway B.Com., M.B.A.Chief Strategy & Business Development Officer
- Mr. Mario TasconeDeputy CEO of Retail